Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases
Clinical trial NCT00127023 · COMPLETED
Trial details
- NCT number
- NCT00127023
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Enrollment
- 944
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.